キナゾリン化合物及びその使用方法 - Ambito Biosciences Colporation

Title:

キナゾリン化合物及びその使用方法

Document Type and Number:

Japanese Patent JP5901634

Kind Code:

B2

Abstract:

Provided herein are quinazoline compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.

More Like This:

WO/2001/007406	NOVEL AMIDE DERIVATIVES
WO/2023/156864	PYRIDAZINONE-BASED COMPOUNDS AS AXL, C-MET, AND MER INHIBITORS AND METHODS OF USE THEREOF
WO/2000/050406	ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES

Inventors:

Michael Jay Hadodo
Mark W. Holladai
Maruto Inn Robototomu

Application Number:

JP2013527261A

Publication Date:

April 13, 2016

Filing Date:

August 31, 2011

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Ambito Biosciences Colporation

International Classes:

C07D401/14; A61K31/517; A61K31/5377; A61K45/00; A61P29/00; A61P35/00; A61P37/02; A61P43/00; C07D403/14; C07D405/14

Foreign References:

WO2003078427A1
WO2003078426A1
WO2003077921A1
US20050038023

Attorney, Agent or Firm:

Toru Ishikawa

Previous Patent: 電気機械のオーバーモールドによる構築

Next Patent: ブリッジトポロジーを用いるスイッチドモード電力コンバータ及びそのス�...